Spots Global Cancer Trial Database for Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases
Official Title: Pilot Study of Resection Combined With Stereotactic Radiosurgery in Patients With Limited (1-3) Brain Metastases
Study ID: NCT00904553
Conditions
Interventions
Study Description
Brief Summary: This study is to look more closely at the tumor removed during your surgery, and to follow your condition after your treatment. The purpose of this study is to determine what side effects are common or more rare from this treatment, how well the treatment has worked for you, and to track whether you develop other brain metastases.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York, United States
Contact Details
Name: Michael Milano, MD PhD
Affiliation: Department of Radiation Oncology, University of Rochester Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
